Covered recipient · General Payments record
LISA QUEEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$793.68
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.26 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $173.68 | 10 |
| DEXCOM, INC. | $41.33 | 2 |
| Abbott Laboratories | $35.78 | 2 |
| Amgen Inc. | $19.28 | 1 |
| Amneal Pharmaceuticals LLC | $14.39 | 1 |
| Xeris Pharmaceuticals, Inc. | $13.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.82 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125381048 | CMS |
| Abbott Laboratories | $19.96 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125381050 | CMS |
| ABBVIE INC. | $19.59 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048216 | CMS |
| ABBVIE INC. | $9.09 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048218 | CMS |
| ABBVIE INC. | $25.06 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048220 | CMS |
| ABBVIE INC. | $17.51 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048222 | CMS |
| ABBVIE INC. | $19.34 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048224 | CMS |
| ABBVIE INC. | $12.08 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048226 | CMS |
| ABBVIE INC. | $19.33 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048228 | CMS |
| ABBVIE INC. | $14.07 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048230 | CMS |
| ABBVIE INC. | $14.93 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048232 | CMS |
| ABBVIE INC. | $22.68 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048234 | CMS |
| Amgen Inc. | $19.28 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117358920 | CMS |
| Amneal Pharmaceuticals LLC | $14.39 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139215378 | CMS |
| Dexcom, Inc. | $20.15 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153375135 | CMS |
| Dexcom, Inc. | $21.18 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153375137 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.80 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144633253 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.